Press release
Primary Sclerosing Cholangitis Market is Expected to Show a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies - NGM Biopharma, Mirium Pharma
Primary Sclerosing Cholangitis Market Outlook
DelveInsight's 'Primary Sclerosing Cholangitis (PSC) Market Insights, Epidemiology, and Market Forecast - 2032' report delivers an in-depth understanding of the Primary Sclerosing Cholangitis, historical and forecasted epidemiology as well as the market trends in the United States, the EU-5 (Germany, Spain, Italy, France, and United Kingdom), Nordic countries (Sweden, Finland, Denmark, and Norway), and Japan.
Download Sample Report to know more @ https://www.delveinsight.com/sample-request/primary-sclerosing-cholangitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Primary Sclerosing Cholangitis Overview
Primary sclerosing cholangitis (PSC) is a rare progressive disorder characterized by inflammation, thickening, and abnormal formation of fibrous tissue (fibrosis) within the passages that carry bile from the liver (bile ducts). Both the bile ducts within the liver (intrahepatic) and outside the liver (extrahepatic) are affected, resulting in the obstruction or interruption of bile flow from the liver (cholestasis).
Click here to learn more about the Primary Sclerosing Cholangitis Market Landscape @https://www.delveinsight.com/report-store/primary-sclerosing-cholangitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Key Highlights from Primary Sclerosing Cholangitis Market Report
Key Companies include Gilead Sciences, Phenex Pharmaceuticals, HighTide Therapeutics, Mirum Pharmaceuticals, Pliant Therapeutics, Inc., NGM Biopharmaceuticals, and many others.
Key Therapies include Cilofexor, HTD 1801, and many others
The marker Size of Primary Sclerosing Cholangitis market is expected to be USD 900 Billion in 2021
Primary Sclerosing Cholangitis market is anticipated to witness growth at a considerable CAGR.
Primary Sclerosing Cholangitis Treatment Market
Primary Sclerosing Cholangitis symptoms by including disease definition, symptoms, causes, physiology, and diagnosis. It also provides Primary Sclerosing Cholangitis treatment algorithms and treatment guidelines for Primary Sclerosing Cholangitis symptoms in the US, the EU-5, Nordic countries, and Japan. High-dose ursodeoxycholic acid is used to treat PSC patients with a trend toward increased survival. Dominant bile duct stenoses should be treated endoscopically. However, liver transplantation is the only therapeutic option for patients with advanced disease. A few major unmet needs in the market include lack of effective therapies, lack of proven surveillance strategies, lack of tools for early detection of malignancies, impact on quality of life (QoL), and lack of surrogate endpoints in clinical trials, among others.
Learn more about the treatment market for Primary Sclerosing Cholangitis @https://www.delveinsight.com/report-store/primary-sclerosing-cholangitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
The Report Covers the Primary Sclerosing Cholangitis Epidemiology Segmented by
Primary Sclerosing Cholangitis prevalent cases
Primary Sclerosing Cholangitis gender-specific prevalent cases
Primary Sclerosing Cholangitis age-specific prevalent cases
Primary Sclerosing Cholangitis subtype-specific cases
Primary Sclerosing Cholangitis Dug Profile and Companies Covered
Gilead Sciences: Cilofexor
Phenex Pharmaceuticals: HTD 180
And many others.
Learn more about the Key Companies and Emerging Therapies in the Primary Sclerosing Cholangitis Market @https://www.delveinsight.com/report-store/primary-sclerosing-cholangitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Table of Contents
Key Insights
Primary Sclerosing Cholangitis Introduction
Executive Summary of Primary Sclerosing Cholangitis
Disease Background and Overview
Primary Sclerosing Cholangitis Epidemiology and Patient Population
Primary Sclerosing Cholangitis Emerging Therapies
Primary Sclerosing Cholangitis Market Outlook
Primary Sclerosing Cholangitis Market Access and Reimbursement of Therapies
Primary Sclerosing Cholangitis Market Drivers
Primary Sclerosing Cholangitis Market Barriers
Appendix
Primary Sclerosing Cholangitis Report Methodology
DelveInsight Capabilities
Disclaimer
Learn about the detailed offerings of the Primary Sclerosing Cholangitis Market Outlook report @ https://www.delveinsight.com/report-store/primary-sclerosing-cholangitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Trending Reports By DelveInsight:
Functional Constipation Market
https://www.delveinsight.com/report-store/chronic-constipation-market
Lebers Hereditary Optic Neuropathy Lhon Market https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market
Inflammatory Breast Cancer Market
https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market
Immune Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market
Visceral Pain Associated With GI Disorders Market
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market
Bullous Pemphigoid Market
https://www.delveinsight.com/report-store/bullous-pemphigoid-market
Cyclin-dependent Kinase-like 5 Deficiency Disorder Market https://www.delveinsight.com/infographics/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market
Myocarditis Market
https://www.delveinsight.com/report-store/myocarditis-market
Recurrent Blood Clots Market
https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market
Zollinger-ellison Syndrome Market
https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market
Age-related Hearing Loss Medical Device Market
https://www.delveinsight.com/blog/age-related-hearing-loss-device-market
Heart Sounds Sensors Market
https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market
Hypoplastic Left Heart Syndrome Hlhs Market
https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market
Infectious Arthritis/Septic Arthritis Market
https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market
Plasmacytoma Market
https://www.delveinsight.com/report-store/plasmacytoma-market
Agoraphobia Market
https://www.delveinsight.com/report-store/agoraphobia-market
Clinically Isolated Syndrome CIS Market
https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market
Fucosidosis Market
https://www.delveinsight.com/report-store/fucosidosis-market
Major Depressive Disorder Market
https://www.delveinsight.com/report-store/major-depressive-disorder-market
Neuronal Ceroid-lipofuscinoses Market
https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market
Orthotic Devices Market
https://www.delveinsight.com/report-store/orthotic-devices-market
DelveInsight Business Research LLP
Adya Kaul
info@delveinsight.com
https://www.delveinsight.com
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Primary Sclerosing Cholangitis Market is Expected to Show a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies - NGM Biopharma, Mirium Pharma here
News-ID: 3251068 • Views: …
More Releases from DelveInsight Business Research LLP
Myelofibrosis Pipeline Report 2025 by DelveInsight: Key Insights into Clinical S …
DelveInsight's "Myelofibrosis Pipeline Insight" report provides comprehensive insights about 35+ companies and 40+ pipeline drugs in the Myelofibrosis pipeline landscape. It covers the Myelofibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Myelofibrosis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights! Download DelveInsight's comprehensive Myelofibrosis…
Hemophilia Pipeline Landscape Report 2025: DelveInsight's Exclusive Report on Cu …
DelveInsight's "Hemophilia Pipeline Insight" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Hemophilia pipeline landscape. It covers the Hemophilia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hemophilia therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights! Download DelveInsight's comprehensive Hemophilia…
DelveInsight's NMIBC Pipeline 2025: Unveiling Drug Development Progress, Clinica …
DelveInsight's, "Non Muscle Invasive Bladder Cancer Pipeline Insight" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Non Muscle Invasive Bladder Cancer pipeline landscape. It covers the Non Muscle Invasive Bladder Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Non Muscle Invasive Bladder Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive…
Hearing Loss Pipeline 2025 by DelveInsight: Exploring Novel Mechanisms of Action …
DelveInsight's "Hearing Loss Pipeline Insight" report provides comprehensive insights about 32+ companies and 35+ pipeline drugs in Hthe earing Loss pipeline landscape. It covers the Hearing Loss pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hearing Loss therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights!…
More Releases for Primary
Premier Primary Care Medicine Recognized as Top-Rated Primary Care Physician in …
Premier Primary Care Medicine has been recognized as the top-rated primary care physician in Marietta, Georgia. The designation highlights the practice's commitment to accessible, high-quality primary care, same-day and next-day appointments, and an approach centered on long-term patient relationships.
Marietta, GA - September 16, 2025 - Premier Primary Care Medicine [https://www.premierpcmed.com/] has been recognized as the top-rated primary care physician in Marietta, Georgia. The designation highlights the practice's commitment to accessible,…
Direct Primary Care Market
Direct Primary Care Market Worth 80.4 Bn 2031- Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Direct Primary Care Market"- By Type (Clinical Services, Telehealth Services, Laboratory Services, Consultative Services), Care Setting (Office-Based DPC Practices, Home-Based DPC Practices, Telehealth-Only DPC Practices, Hybrid DPC Practices), End Users (Individuals, Employers, Small Businesses, Large Corporations, Insurance Companies (offering DPC as…
Primary Sclerosing Cholangitis Market
Primary Sclerosing Cholangitis (PSC) is a rare, chronic liver disease characterized by inflammation and scarring of the bile ducts, leading to liver damage and, ultimately, liver failure. The disease progresses slowly and often goes unnoticed in its early stages. Although the exact cause of PSC remains unknown, it is commonly associated with other inflammatory bowel diseases, particularly ulcerative colitis. The management of PSC includes symptom control, slowing disease progression, and…
Primary Healthcare Conference 2023
3rd World Congress on Primary Healthcare and Medicare Summit
Mercure Roma West, Viale degli Eroi di Cefalonia, 301, 00128 Rome, Italy
Email primaryhealthcare@pulsusgathering.org
On behalf of the Conference Organizing Committee, we would like to invite all of you for the "3rd Word Congress on Primary Healthcare and Medicare", which is going to be held in Rome, Italy on September 21-23, 2023. Primary Healthcare 2023 focuses on the basic theme "To Manifest the Multimorbidity…
Primary Lithium Battery (Primary Lithium Batteries) Market Key Companies and Ana …
The global lithium primary batteries market size will grow from $2.83 billion in 2022 to $2.9 billion in 2023 at a compound annual growth rate (CAGR) of 2.5%
Global " Primary Lithium Battery (Primary Lithium Batteries) Market" 2022 Reports give a Key study on the industry status of the Primary Lithium Battery (Primary Lithium Batteries) Manufacturer with the specific statistics, meaning, definition, SWOT Analysis, expert opinion, and recent development across…
Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include:
1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk…
